Skinny Labels, Big Savings Act (S. 43/H.R. 6485); Eliminating Thickets to Increase Competition (ETHIC) Act (S. 2276/H.R. 3269).
Literal federal measure citations: S. 43, H.R. 6485, S. 2276, H.R. 3269
2026 · 1st Quarter (Jan 1 - Mar 31)
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
Filed by COVINGTON & BURLING LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- $450,000.00
- Expenses
- Not reported
- Registrant
- COVINGTON & BURLING LLP
- Filing UUID
- cf6cd7a5-d6ee-4ed0-b861-047a616e7182
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Biosimilars Access and Affordability Act (S. 5459); Skinny Labels, Big Savings Act (S. 43/H.R. 6485); Eliminating Thickets to Increase Competition (ETHIC) Act (S. 2276/H.R. 3269); Expedited Access to Biosimilars Act (S. 1414); Biosimilar Red Tape Elimination Act (S. 1954/H.R. 5526); CLEAR Act (H.R.7140); Artificial Intelligence-Ready Data Act (S.4098); Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); Drug Competition Enhancement Act (S.1040); America's Living Library Project Bill (S. 4023); Securing Essential Components for U.S. Readiness in Essential Pharmaceuticals (SECURE Rx) Act of 2026 (discussion draft); improvements to the National Childhood Vaccine Injury Act of 1986; Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act (S. 3788).
Literal federal measure citations: S. 5459, S. 43, H.R. 6485, S. 2276, H.R. 3269, S. 1414, S. 1954, H.R. 5526, H.R.7140, S.4098, S. 1096, S.1040, S. 4023, S. 3788
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.